Clinical and instrumental study of the efficacy of a new sebum control cream

Journal of Cosmetic Dermatology

Volumn 6, Issue 2, 2007, Pages 113-118

  Dobrev, Hristo ^a  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

Author keywords

Essential fatty acids; Oily skin; Plants; Saw palmetto; Skin bioengineering

Indexed keywords

DAY CREAM AROMA PURE; KERNEL OIL; PLANT EXTRACT; POLYPHENOL; PYRIDOXINE; REGU SEB; SABAL EXTRACT; SESAME SEED OIL; TITANIUM DIOXIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHEEK; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOREHEAD; HUMAN; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PHOTOMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SCORING SYSTEM; SEBACEOUS GLAND DISEASE; SEBUM SECRETION; TREATMENT DURATION; WINTER;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; DERMATOLOGIC AGENTS; FACE; FEMALE; FRUIT; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; QUESTIONNAIRES; SAPOTACEAE; SEBACEOUS GLANDS; SEBUM; SERENOA; SESAMUM; SKIN;

EID: 34249791495     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2007.00306.x     Document Type: Article

References (17)

1. Mercurio M, Gogstetter D. Androgen physiology and the cutaneous pilosebaceous unit. J Gend Specif Med 2000; 3: 59-64.
2. Chen W, Zouboulis CC, Orfanos CE. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders. Dermatology 1996; 193: 177-84.
3. Thiboutot D, Bayne E, Thorne J et al. Immunolocalization of 5alpha-reductase isozymes in acne lesions and normal skin. Arch Dermatol 2000; 136: 1125-9.
4. Cilotti A, Danza G, Serio M. Clinical application of 5 alpha-reductase inhibitors. J Endocrinol Invest 2001; 24: 199-203.
5. Imperato-McGinley J, Gautier T, Cai LQ et al. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab 1993; 76: 524-8.
6. Leyden J, Bergfeld W, Drake L, et al. A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. J Am Acad Dermatol 2004; 50: 443-7.
7. Délos S, Carsol J, Ghazarossian E et al. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts. J Steroid Biochem Mol Biol 1995; 55: 375-83.
8. Liang T, Liao S. Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids. Biochem J 1992; 285 (2): 557-62.
9. Liang T, Liao S. Growth suppression of hamster flank organs by topically application of gamma-linolenic and other fatty acid inhibitors of 5alpha-reductase. J Invest Dermatol 1997; 109: 152-7.
10. Gordon A, Shaughnessy A. Saw palmetto for prostate disorders. Am Fam Physician 2003; 67: 1281-3.
11. Wilt T, Ishani A, MacDonald R. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev 2002; (3): CD001423.
12. Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med 2002; 8: 143-52.
13. Raynaud JP, Cousse H, Martin PM. Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon. J Steroid Biochem Mol Biol 2002; 82: 233-9.
14. Khallouki F, Spiegelhalder B, Bartsch H, Owen RW. Secondary metabolites of the argan tree (Morocco) may have disease prevention properties. Afr J Biotechnol 2005; 4: 381-8.
15. Hughes-Formella B, Willers C, Kröncke U, Wunderlich O. Evaluation of the sebum regulation efficacy of REGU®-SEB in 12 subjects with seborrhoic skin condition. Substantiation File of REGU®-SEB, Pentapharm Ltd., Basel, Switzerland.
16. Pierard-Franchimont C, Martalo O, Richard A, Rougier A, Pierard GE. Sebum rheology evaluated by two methods in vivo. Split-face study of the effect of a cosmetic formulation. Eur J Dermatol 1999; 9: 455-7.
17. Piccardi N, Piccirilli A, Choulot JC et al. Pharmacological and clinical activities of 5-alpha avocuta: Applicaton for the management of androgenic disorders. J Invest Dermatol 2004 ; 123: A1-A77 (Abstract No 407).